Ring chromosome 3, r(3), is an extremely rare cytogenetic abnormality with clinical heterogeneity and only 12 cases reported in the literature. Here, we report a 1-year-old girl presenting distinctive facial features, developmental delay, and congenital heart defects with r(3) and a ∼10-Mb deletion of chromosome 3pterp25.3 (61,891-9,979,408) involving 42 known genes which was detected using G-banding karyotyping and CytoScan 750K-Array. The breakpoints in r(3) were mapped at 3p25.3 and 3q29. We also analyzed the available information on the clinical features of the reported cases with r(3) and 3p deletion syndrome in order to provide more valuable information of genotype-phenotype correlations. To our knowledge, this is the largest detected fragment described in r(3) cases and the second r(3) study using whole-genome microarray.

Keywords:
3p deletion, Chromosome microarray, Ring chromosome
1.
Barajas-Barajas LO, Velarde-Felix S, Elizarraras-Rivas J, Hernandez-Zaragoza G, Vazguez-Herrera JA: De novo ring chromosome 3 in a girl with hypoplastic thumb and coloboma of iris. Genet Couns 12:151-156 (2001).
2.
Barber JC: Terminal 3p deletions: phenotypic variability, chromosomal non-penetrance, or gene modification? Am J Med Genet A 146A:1899-1901 (2008).
3.
Ellery PM, Ellis RJ, Holder SE: Interstitial 3p25 deletion in a patient with features of 3p deletion syndrome: further evidence for the role of SRGAP3 in mental retardation. Clin Dysmorphol 23:29-31 (2014).
4.
Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, et al: Neuronal cell adhesion genes and antidepressant response in three independent samples. Pharmacogenomics J 15:538-548 (2015).
5.
Fernandez T, Morgan T, Davis N, Klin A, Morris A, et al : Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome. Am J Hum Genet 74:1286-1293 (2004).
6.
Gibbs EM, Eeldman EL, Dowling JJ: The role of MTMR14 in autophagy and in muscle disease. Autophagy 6:819-820 (2010).
7.
Green EK, Priestley MD, Waters J, Maliszewska C, Latif F, Maher ER: Detailed mapping of a congenital heart disease gene in chromosome 3p25. J Med Genet 37:581-587 (2000).
8.
Grozeva D, Carss K, Spasic-Boskovic O, Tejada MI, Gecz J, et al: Targeted next-generation sequencing analysis of 1,000 individuals with intellectual disability. Hum Mutat 36:1197-1204 (2015).
9.
Guilherme RS, Bragagnolo S, Pellegrino R, Christofolini DM, Takeno SS, et al: Clinical, cytogenetic and molecular study in a case of r(3) with 3p deletion and review of the literature. Cytogenet Genome Res 134:325-330 (2011a).
10.
Guilherme RS, Meloni VF, Kim CA, Pellegrino R, Takeno SS, et al: Mechanisms of ring chromosome formation, ring instability and clinical consequences. BMC Med Genet 12:171 (2011b).
11.
Guilherme RS, Kim CA, Alonso LG, Honjo RS, Meloni VA, et al: Ring chromosome 10: report on two patients and review of the literature. J Appl Genet 54:35-41 (2013).
12.
Huang L, Chardon JW, Carter MT, Friend KL, Dudding TE, et al: Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia. Orphanet J Rare Dis 7:67 (2012).
13.
Kashevarova AA, Nazarenko LP, Schultz-Pedersen S, Skryabin NA, Salyukova OA, et al: Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability. Mol Cytogenet 7:97 (2014).
14.
Kaur A, Khetarpal S: 3p deletion syndrome. Indian Pediatr 50:795-796 (2013).
15.
Kellogg G, Sum J, Wallerstein R: Deletion of 3p25.3 in a patient with intellectual disability and dysmorphic features with further definition of a critical region. Am J Med Genet A 161A:1405-1408 (2013).
16.
Kitatani M, Takahashi H, Yasuda J, Chen CC, Ida F, et al: A case of ring chromosome 3, 46,XX,-3, r(3)(p26q29). Jinrui Idengaku Zasshi 29:157-162 (1984).
17.
Knijnenburg J, van Haeringen A, Hansson KB, Lankester A, Smit MJ, et al: Ring chromosome formation as a novel escape mechanism in patients with inverted duplication and terminal deletion. Eur J Hum Genet 15:548-555 (2007).
18.
Kosztolányi G: Does ‘ring syndrome' exist? An analysis of 207 case reports on patients with a ring autosome. Hum Genet 75:174-179 (1987).
19.
Kotecha UH, Movva S, Sharma D, Verma J, Puri RD, et al: Molecular evaluation of a novel missense mutation and an insertional truncating mutation in SUMF1 gene. Indian J Med Res 140:55-59 (2014).
20.
Kuechler A, Zink AM, Wieland T, Lüdecke HJ, Cremer K, et al: Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome. Eur J Hum Genet 23:753-760 (2015).
21.
Kusuma L, Dinesh SM, Savitha MR, Krishnamurthy B, Narayanappa D, Ramachandra NB: A maiden report on CRELD1 single-nucleotide polymorphism association in congenital heart disease patients of Mysore, South India. Genet Test Mol Biomarkers 15:483-487 (2011).
22.
Liu Y, Zhang Y, Zhao D, Dong R, Yang X, et al: Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 168B:258-264 (2015).
23.
Malmgren H, Sahlén S, Wide K, Lundvall M, Blennow E: Distal 3p deletion syndrome: detailed molecular cytogenetic and clinical characterization of three small distall deletions and review. Am J Med Genet A 143A: 2143-2149 (2007).
24.
McCullough BJ, Adams JC, Shilling DJ, Feeney MP, Sie KC, Tempel BL: 3p-syndrome defines a hearing loss locus in 3p25.3. Hear Res 224:51-60 (2007).
25.
McKinley M, Colley A, Sinclair P, Donnai D, Andrews T: De novo ring chromosome 3: a new case with a mild phenotype. J Med Genet 28:536-538 (1991).
26.
Mukerjee D, Burdette WJ: Multiple congenital anomalies associated with a ring 3 chromosome and translocated 3/X chromosome. Nature 212:153-155 (1966).
27.
Narahara K, Kikkawa K, Murakami M, Hiramoto K, Namba H, et al: Loss of the 3p25.3 band is critical in the manifestation of del(3p) syndrome: karyotype-phenotype correlation in cases with deficiency of the distal portion of the short arm of chromosome 3. Am J Med Genet 35:269-273 (1990).
28.
Papuc SM, Hackmann K, Andrieux J, Vincent-Delome C, Budisteanu M, et al: Microduplication of 3p26.33p26.2 containing CRBN gene in patients with intellectual disability and behavior abnormalities. Eur J Med Genet 58:319-323 (2015).
29.
Peltekova IT, Macdonald A, Armour CM: Microdeletion on 3p25 in a patient with features of 3p deletion syndrome. Am J Med Genet A 158A:2583-2586 (2012).
30.
Picciano DJ, Berlin CM, Davenport SL, Jacobson CB: Human ring chromosomes: a report of five cases. Ann Genet 15:241-247 (1972).
31.
Pohjola P, de Leeuw N, Penttinen M, Kääriäinen H: Terminal 3p deletions in two families-correlation between molecular karyotype and phenotype. Am J Med Genet A 152A:441-446 (2010).
32.
Robinson SW, Morris CD, Goldmuntz E, Reller MD, Jones MA, et al: Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet 72:1047-1052 (2003).
33.
Shuib S, McMullan D, Rattenberry E, Barber RM, Rahman F, et al: Microarray based analysis of 3p25-p26 deletions (3p-syndrome). Am J Med Genet A 149A:2099-2105 (2009).
34.
Tassano E, Biancheri R, Denegri L, Porta S, Novara F, et al: Heterozygous deletion of CHL1 gene: detailed array-CGH and clinical characterization of a new case and review of the literature. Eur J Med Genet 57:626-629 (2014).
35.
Teyssier M, Piperno D, Charrin C: Ring chromosome 3 in a mentally retarded adult dwarf. Ann Genet 34:33-36 (1991).
36.
Wang H, Xue Y, He Y, Zhang J, Wu Y, et al: A case of ring chromosome 3 syndrome. Chin J Med Genet 26:594 (2009).
37.
Wilson GN, Pooley J, Parker J: The phenotype of ring chromosome 3. J Med Genet 19:471-473 (1982).
38.
Witkowski R, Ullrich E, Piede U: Ring chromosome 3 in a retarded boy. Hum Genet 42:345-348 (1978).
39.
You L, Zou J, Zhao H, Bertos NR, Park M, et al: Deficiency of the chromatin regulator BRPF1 causes abnormal brain development. J Biol Chem 290:7114-7129 (2015).
40.
Zhian S, Belmont J, Maslen CL: Specific association of missense mutations in CRELD1 with cardiac atrioventricular septal defects in heterotaxy syndrome. Am J Med Genet A 158A:2047-2049 (2012).
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.